Gofen & Glossberg’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $143M | Sell |
260,457
-2,500
| -1% | -$1.32M | 3.69% | 3 |
|
|
2022
Q3 | $133M | Sell |
262,957
-2,214
| -0.8% | -$1.24M | 3.77% | 3 |
|
|
2022
Q2 | $144M | Sell |
265,171
-1,139
| -0.4% | -$627K | 3.82% | 3 |
|
|
2022
Q1 | $157M | Sell |
266,310
-5,645
| -2% | -$3.24M | 3.59% | 3 |
|
|
2021
Q4 | $181M | Sell |
271,955
-988
| -0.4% | -$617K | 3.92% | 3 |
|
|
2021
Q3 | $156M | Sell |
272,943
-3,464
| -1% | -$1.9M | 3.65% | 3 |
|
|
2021
Q2 | $139M | Sell |
276,407
-609
| -0.2% | -$287K | 3.31% | 3 |
|
|
2021
Q1 | $126M | Sell |
277,016
-6,478
| -2% | -$3.09M | 3.24% | 3 |
|
|
2020
Q4 | $132M | Sell |
283,494
-4,307
| -1% | -$2.02M | 3.62% | 3 |
|
|
2020
Q3 | $127M | Sell |
287,801
-5,472
| -2% | -$2.26M | 3.91% | 3 |
|
|
2020
Q2 | $106M | Sell |
293,273
-5,617
| -2% | -$1.88M | 3.56% | 3 |
|
|
2020
Q1 | $84.8M | Sell |
298,890
-2,494
| -0.8% | -$786K | 3.32% | 3 |
|
|
2019
Q4 | $97.9M | Sell |
301,384
-1,463
| -0.5% | -$444K | 3.11% | 4 |
|
|
2019
Q3 | $88.2M | Sell |
302,847
-5,309
| -2% | -$1.52M | 2.97% | 4 |
|
|
2019
Q2 | $90.5M | Sell |
308,156
-2,751
| -0.9% | -$758K | 3.1% | 2 |
|
|
2019
Q1 | $85.1M | Sell |
310,907
-5,231
| -2% | -$1.3M | 3.02% | 2 |
|
|
2018
Q4 | $70.7M | Sell |
316,138
-8,013
| -2% | -$1.88M | 2.8% | 4 |
|
|
2018
Q3 | $79.1M | Sell |
324,151
-2,164
| -0.7% | -$498K | 2.72% | 4 |
|
|
2018
Q2 | $67.6M | Sell |
326,315
-3,249
| -1% | -$690K | 2.51% | 6 |
|
|
2018
Q1 | $68M | Sell |
329,564
-10,008
| -3% | -$2.1M | 2.55% | 5 |
|
|
2017
Q4 | $64.5M | Sell |
339,572
-2,821
| -0.8% | -$540K | 2.3% | 7 |
|
|
2017
Q3 | $64.8M | Sell |
342,393
-8,578
| -2% | -$1.55M | 2.4% | 5 |
|
|
2017
Q2 | $61.2M | Sell |
350,971
-730
| -0.2% | -$123K | 2.33% | 5 |
|
|
2017
Q1 | $54M | Sell |
351,701
-7,085
| -2% | -$1.08M | 2.12% | 7 |
|
|
2016
Q4 | $50.6M | Sell |
358,786
-6,020
| -2% | -$888K | 2.07% | 7 |
|
|
2016
Q3 | $58M | Sell |
364,806
-4,567
| -1% | -$704K | 2.41% | 3 |
|
|
2016
Q2 | $54.6M | Sell |
369,373
-6,147
| -2% | -$907K | 2.28% | 5 |
|
|
2016
Q1 | $53.2M | Sell |
375,520
-830
| -0.2% | -$111K | 2.26% | 5 |
|
|
2015
Q4 | $53.4M | Sell |
376,350
-1,529
| -0.4% | -$204K | 2.32% | 6 |
|
|
2015
Q3 | $46.2M | Sell |
377,879
-3,197
| -0.8% | -$417K | 2.1% | 8 |
|
|
2015
Q2 | $49.4M | Buy |
381,076
+5,291
| +1% | +$690K | 2.09% | 7 |
|
|
2015
Q1 | $50.5M | Sell |
375,785
-601
| -0.2% | -$77.5K | 2.17% | 6 |
|
|
2014
Q4 | $47.2M | Buy |
376,386
+1,700
| +0.5% | +$207K | 2.02% | 7 |
|
|
2014
Q3 | $45.6M | Sell |
374,686
-1,270
| -0.3% | -$154K | 2.01% | 9 |
|
|
2014
Q2 | $44.4M | Sell |
375,956
-4,160
| -1% | -$490K | 1.96% | 9 |
|
|
2014
Q1 | $47.3M | Sell |
380,116
-6,105
| -2% | -$726K | 2.21% | 6 |
|
|
2013
Q4 | $43M | Buy |
386,221
+6
| +0% | +$597 | 2.02% | 8 |
|
|
2013
Q3 | $35.6M | Sell |
386,215
-2,048
| -0.5% | -$185K | 1.83% | 13 |
|
|
2013
Q2 | $32.9M | Buy |
+388,263
| New | +$32.3M | 1.78% | 12 |
|
Other funds holding TMO
Gofen & Glossberg's TMO Position: Q4 2022 in Review
Gofen & Glossberg reduced its Thermo Fisher Scientific (TMO) stake by 0.95% in Q4 2022, selling an estimated $1.32M and leaving 260,457 shares worth $143M. The position accounts for 3.69% of the portfolio, ranked #3.
Gofen & Glossberg first reported a position in TMO in Q2 2013 and has held it in 39 quarters since. The position peaked at $181M in Q4 2021. 2,374 funds tracked by Wall St. Rank hold TMO as of Q4 2022.
- Gofen & Glossberg held 260,457 shares of Thermo Fisher Scientific worth $143M as of Q4 2022.
- Gofen & Glossberg sold 2,500 Thermo Fisher Scientific shares in Q4 2022, an estimated $1.32M.
- Thermo Fisher Scientific made up 3.69% of Gofen & Glossberg's portfolio in Q4 2022, its #3 holding.
- Gofen & Glossberg first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 39 quarters since.
- Gofen & Glossberg's Thermo Fisher Scientific position peaked at $181M in Q4 2021.
- 2,374 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2022.
Based on Gofen & Glossberg's 13F filing for Q4 2022, filed 13 Jan 2023.